KayserBetten is issuing a Class I recall for its IDA pediatric care beds due to a serious risk of injury or death from entrapment. The U.S. Food and Drug Administration (FDA) is aware of this correction, which addresses a design flaw similar to a model involved in a child's death outside the U.S.
The issue stems from the hand control's adjustment function. If the adjustment functions are not locked with a provided key when the patient is unattended, there is an increased risk that the patient or other children could operate the control, potentially trapping themselves under the bed frame or between the bed frame and the floor.
KayserBetten is replacing the hand control on all affected KayserBett IDA beds in the U.S. with a modified version featuring an automatic locking function. This replacement will be performed by an authorized service technician from Mobility Unlimited Inc. (KayserBetten US) at no cost to the customer.
As of April 22, KayserBetten has reported no serious injuries or deaths associated with this issue in the U.S. The FDA emphasizes that this is the most serious type of recall, indicating that continued use without correction may cause serious injury or death.